Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children

NCT00716976 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00716976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00716976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
June 23, 2008
Completion date
June 30, 2021
Enrollment
131 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, central nervous system tumor, childhood germ cell tumor, extragonadal germ cell tumor, liver cancer, neuroblastoma, ototoxicity, ovarian cancer, sarcoma